MONTREAL, Feb. 7 /PRNewswire-FirstCall/ - CryoCath , will hold a conference call to discuss its first quarter financial results at 10:00 a.m. (Eastern Time) on February 14, 2006. The Company will report its results in a press release to be issued at 7:00 a.m. the morning of the call.
A live audio webcast of the conference call will be available through http://www.cryocath.com. Please connect to this website at least 15 minutes prior to the conference call to ensure adequate time for any software download that may be needed to hear the webcast. A replay of the webcast will be available for 90 days starting on February 14, 2006 at www.cryocath.com. A replay of the conference call will also be available by telephone on February 14, 2006 through February 21, 2006. To access the replay, dial 416-640-1917 OR 877-289-8525 and enter reservation number 2117643.
About CryoCath Technologies Inc.
CryoCath -www.cryocath.com- is a medical technology company that leads the world in cryotherapy products to treat cardiovascular disease. With a priority focus on providing physicians with a complete solution of catheter and surgical products to treat cardiac arrhythmias, CryoCath has multiple products approved in the U.S., across Europe and several ROW countries. The Company is developing additional products to expand its pipeline of products to treat cardiac arrhythmias and has development projects for the treatment of cardiac ischemia (angina) and peripheral arterial disease (PAD).
CryoCath Technologies Inc.
CONTACT: Mike Polonsky, Investor Relations, Tel: (416) 815-0700, Ext 231,Fax: (416) 815-0080, E-Mail: mpolonsky@equicomgroup.com
